acetylcysteine and Alveolitis, Fibrosing

acetylcysteine has been researched along with Alveolitis, Fibrosing in 69 studies

Research

Studies (69)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.90)18.7374
1990's13 (18.84)18.2507
2000's20 (28.99)29.6817
2010's29 (42.03)24.3611
2020's5 (7.25)2.80

Authors

AuthorsStudies
Avdeev, SN; Izquierdo, JL; Micheletto, C; Pacheco Gallego, MC; Rada Escobar, RA1
Guan, Y; Li, G; Liu, N; Ma, Z; Wang, R; Yao, S; Zhao, L1
Li, G; Liu, Y; Niu, D; Qu, Y; Ye, W; Zhang, Q; Zhao, X; Zhao, Z1
El Kiki, SM; Hasan, HF; Mansour, HH; Omran, MM1
Li, SQ; Zou, H1
Chen, JM; Hu, Y; Li, CL; Li, HP; Li, QH; Li, Y; Wang, LS; Weng, D1
Chen, J; Chen, M; Huang, H; Li, X; Liu, F; Liu, M; Wang, J; Wu, H1
Cottin, V2
Jiang, H; Yin, G; Zhang, C; Zhang, H1
Ancochea, J; Valenzuela, C1
Bai, YP; Chen, G; Hao, XH; He, YL; Jin, YL; Li, QZ; Liu, N; Yao, SQ; Yuan, JX; Yun, X; Zhang, L; Zhang, ZF1
Du, ZZ; Li, L; Sun, X; Wang, CZ; Wu, Q; Yu, HZ1
Chen, C; Guan, X; Ouyang, B; Quinn, DA1
Álvarez-Sala Walther, R; Gómez Carrera, L1
Chen, J; Chen, R; Feng, L; Jiang, Z; Li, X; Lou, J; Xia, H; Xiao, Y; Yin, X; Yu, M; Zhang, X; Zhu, L1
Li, T; Wang, HQ1
Martinez, F; Noth, I; Raghu, G1
Albera, C; Behr, J; Crestani, B; Kirchgaessler, K; Wells, A1
Behr, J; Costabel, U1
Haraguchi, N; Hizawa, N; Ishii, T; Ishii, Y; Kikuchi, N; Masuko, H; Morishima, Y; Sakamoto, T; Warabi, E; Yageta, Y; Yamadori, T; Yanagawa, T1
Barron, JT; Grady, EC; Wagner, RH1
Zhang, CL; Zhang, H1
Chen, J; Guan, XD; Li, XF; Ouyang, B; Wu, JF1
Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ; Raghu, G1
Ko, JL; Lee, H; Tang, SC; Wang, PH; Wu, CH1
Auten, RL; Brass, DM; Dunkel, MK; Fattman, CL; Hollingsworth, JW; Latoche, JD; Li, Z; Potts-Kant, E; Reilly, SM; Spencer, JC1
Abbasi, H; Aran, S; Ghaffari, A; Keshavarz, A; Seifirad, S; Taslimi, S1
Behr, J2
Hirano, S; Iikura, M; Izumi, S1
Hanada, S; Kishi, K; Uruga, H1
De Capadocia Rosell, J; Jiménez Vizuete, JM; Lozano Serrano, B; Mateo Cerdá, CM1
Chen, L; Li, J; Li, S; Li, W; Su, X; Yan, G; Yang, X1
El-Maraghy, SA; Hamdy, MA; Kortam, MA1
Lota, HK; Wells, AU1
Arreola, JL; Barrios, R; Cisneros-Lira, J; Gaxiola, M; Kala, SV; Lieberman, MW; Pardo, A; Ramírez, R; Ruiz, V; Selman, M1
Blesa, S; Bulbena, O; Closa, D; Cortijo, J; Estrela, JM; Martinez-Losa, M; Morcillo, EJ; Prats, N; Serrano-Mollar, A1
Cerdá, M; Cortijo, J; Llombart-Bosch, A; Martinez-Losa, M; Mata, M; Morcillo, EJ; Ruíz, A; Santangelo, F; Serrano-Mollar, A1
Flaherty, KR; Lynch, JP; Martinez, FJ; Thannickal, VJ1
Armutcu, F; Iraz, M; Kotuk, M; Kuku, I; Ozen, S; Ulu, R; Yildirim, Z1
Hashimoto, K; Imanaka, K; Iwasaki, H; Kuwata, Y; Ohnishi, H; Sakamoto, H; Tada, K; Tomioka, H1
Behr, J; Buhl, R; Capron, F; Corvasce, G; Costabel, U; De Vuyst, P; Dekhuijzen, R; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Montanari, M; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B1
Hunninghake, GW1
Hull, JH1
Bhowmik, A; Rajakulasingam, R; Toma, TP1
Nathan, SD1
Wells, AU1
Eickelberg, O; Günther, A; Markart, P; Seeger, W1
Collard, HR; King, TE; Walter, N1
Bennett, L; Crouse, R; Feldstein, D1
Aburatani, H; Fukayama, M; Goto, A; Ishikawa, S; Kuriyama, T; Li, CP; Murata, K; Niki, T; Ota, S; Ruriko, UM1
Oehme, FW; Onyeama, HP1
MacNee, W; Rahman, I1
Buhl, R; Kampf, S; Magnussen, H; Meyer, A1
Brien, JF; Leeder, RG; Massey, TE1
DeRemee, RA1
Buhl, R; Magnussen, H; Meyer, A1
Buhl, R; Meyer, A; Vogelmeier, C1
Behr, J; Degenkolb, B; Krombach, F; Maier, K; Vogelmeier, C1
Entzian, P1
Hagiwara, SI; Ishii, Y; Kitamura, S1
Bioque, G; Cerdá-Nicolás, M; Cortijo, J; Esteras, A; Estrela, JM; Llombart-Bosch, A; Morcillo, EJ; Santangelo, F; Serrano, A1
Behr, J; Degenkolb, B; Krombach, F; Vogelmeier, C1
Jeffery, PK; Laurent, GJ; McAnulty, RJ; Sarnstrand, B; Shahzeidi, S1
Ruffmann, R; Wendel, A1
Magnussen, H; Meyer, A1
Nolte, D1
Giri, SN; Hyde, DM; Schiedt, MJ1

Reviews

12 review(s) available for acetylcysteine and Alveolitis, Fibrosing

ArticleYear
[Research on the therapeutic effects of drugs on patients with pneumoconiosis in China].
    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2016, Jul-20, Volume: 34, Issue:7

    Topics: Acetylcysteine; Benzylisoquinolines; Bronchoalveolar Lavage; China; Forced Expiratory Volume; Humans; Pneumoconiosis; Pulmonary Fibrosis; Quinolines; Research; Respiratory Tract Infections; Treatment Outcome; X-Ray Film

2016
The evolving pharmacotherapy of pulmonary fibrosis.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1

    Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome

2013
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:8

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Connective Tissue Growth Factor; Eicosanoids; Endothelin-1; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Molybdenum; Protein Kinase Inhibitors; Proteins; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Relaxin; Renin-Angiotensin System; Tumor Necrosis Factor-alpha

2004
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
    Clinics in chest medicine, 2006, Volume: 27, Issue:1 Suppl 1

    Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides

2006
[Pulmonary fibrosis--a therapeutic dilemma?].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Apr-15, Volume: 101, Issue:4

    Topics: Acetylcysteine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Benzamides; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Sulfonamides

2006
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
    Proceedings of the American Thoracic Society, 2006, Volume: 3, Issue:4

    Topics: Acetylcysteine; Anticoagulants; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Pyridones; Quality of Life; Recombinant Proteins

2006
[Idiopathic interstitial pneumonia: treatment].
    Revue des maladies respiratoires, 2006, Volume: 23, Issue:4 Pt 2

    Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors

2006
A literature review of paraquat toxicity.
    Veterinary and human toxicology, 1984, Volume: 26, Issue:6

    Topics: Acetylcysteine; Animals; Butylated Hydroxytoluene; Clofibrate; Collagen; Diquat; Drug Synergism; Humans; Niacin; Oxygen; Paraquat; Pulmonary Fibrosis; Rats; Superoxide Dismutase; Vitamin E

1984
Oxidants/antioxidants in idiopathic pulmonary fibrosis.
    Thorax, 1995, Volume: 50 Suppl 1

    Topics: Acetylcysteine; Adult; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Glutathione; Humans; Lung; Male; Middle Aged; Oxidants; Prednisolone; Pulmonary Fibrosis

1995
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy.
    Chest, 1996, Volume: 110, Issue:6 Suppl

    Topics: Acetylcysteine; Aerosols; Antioxidants; Glutathione; HIV Infections; Humans; Lung; Lung Diseases; Protease Inhibitors; Pulmonary Fibrosis

1996
[New therapy concepts in fibrosing lung diseases].
    Pneumologie (Stuttgart, Germany), 1996, Volume: 50, Issue:9

    Topics: Acetylcysteine; Glutathione; Humans; Prodrugs; Pulmonary Fibrosis

1996
GSH rescue by N-acetylcysteine.
    Klinische Wochenschrift, 1991, Nov-15, Volume: 69, Issue:18

    Topics: Acetylcysteine; Acquired Immunodeficiency Syndrome; Glutathione; Humans; Pulmonary Fibrosis; Respiratory Distress Syndrome

1991

Trials

6 trial(s) available for acetylcysteine and Alveolitis, Fibrosing

ArticleYear
Treatment switching in idiopathic pulmonary fibrosis: from triple therapy to enrollment into a clinical investigational drug trial.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2013, Sep-01, Volume: 30 Suppl 1

    Topics: Acetylcysteine; Azathioprine; Double-Blind Method; Drugs, Investigational; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Treatment Outcome

2013
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
    The New England journal of medicine, 2012, May-24, Volume: 366, Issue:21

    Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Prednisone; Pulmonary Fibrosis; Treatment Outcome; Vital Capacity

2012
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis.
    Respirology (Carlton, Vic.), 2005, Volume: 10, Issue:4

    Topics: Acetylcysteine; Administration, Inhalation; Aged; Antigens; Antigens, Neoplasm; Biomarkers; Expectorants; Female; Follow-Up Studies; Glycoproteins; Health Status; Humans; Male; Middle Aged; Mucin-1; Mucins; Pilot Projects; Pulmonary Fibrosis; Quality of Life; Radiography; Respiratory Function Tests; Treatment Outcome

2005
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
    The New England journal of medicine, 2005, Nov-24, Volume: 353, Issue:21

    Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity

2005
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.
    The European respiratory journal, 1994, Volume: 7, Issue:3

    Topics: Acetylcysteine; Administration, Oral; Bronchoalveolar Lavage Fluid; Epithelium; Female; Glutathione; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis

1994
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine.
    The European respiratory journal, 2002, Volume: 19, Issue:5

    Topics: Acetylcysteine; Administration, Oral; Adult; Bronchoalveolar Lavage Fluid; Female; Free Radical Scavengers; Glutathione; Humans; Interleukin-8; Male; Middle Aged; Oxidative Stress; Peroxidase; Prospective Studies; Pulmonary Fibrosis

2002

Other Studies

51 other study(ies) available for acetylcysteine and Alveolitis, Fibrosing

ArticleYear
N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:13

    Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; COVID-19 Drug Treatment; Glutathione; Humans; Pulmonary Fibrosis; Quality of Life

2022
N-acetylcysteine alleviates pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles in male rats: involvement of the NF-κB signaling pathway.
    Ecotoxicology and environmental safety, 2022, Volume: 241

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Indium; Lung; Lung Injury; Male; Nanoparticles; NF-kappa B; Pulmonary Alveolar Proteinosis; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Tin Compounds; Tumor Necrosis Factor-alpha

2022
S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 157

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Mice; NF-E2-Related Factor 2; NF-kappa B; Pulmonary Fibrosis; Transforming Growth Factor beta1

2023
Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ.
    Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:12

    Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Bleomycin; Lipid Peroxidation; Lung; Male; NF-kappa B; Oxidative Stress; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Rats; Sirtuin 1

2020
Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:8

    Topics: Acetylcysteine; Convalescence; COVID-19; COVID-19 Drug Treatment; Early Medical Intervention; Glucocorticoids; Humans; Indoles; Pulmonary Fibrosis; Pyridones; SARS-CoV-2

2021
Effects of particulate matter from straw burning on lung fibrosis in mice.
    Environmental toxicology and pharmacology, 2017, Volume: 56

    Topics: Acetylcysteine; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Fires; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Particle Size; Particulate Matter; Pulmonary Fibrosis; Random Allocation; Tumor Necrosis Factor-alpha

2017
N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis.
    Bioscience reports, 2019, 07-31, Volume: 39, Issue:7

    Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Crystallization; Disease Models, Animal; Female; Gene Expression Regulation; Glutathione Peroxidase; Interleukin-1beta; Interleukin-4; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; Nitric Oxide Synthase Type II; Oxidative Stress; Pulmonary Fibrosis; Reactive Oxygen Species; Silicon Dioxide; Silicosis; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthine Oxidase

2019
Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.
    BMC research notes, 2013, Volume: 6 Suppl 1

    Topics: Acetylcysteine; Azathioprine; Disease Management; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Oxygen Inhalation Therapy; Phenylpropionates; Prednisolone; Pulmonary Emphysema; Pulmonary Fibrosis; Pyridazines; Radiography; Smoking

2013
High-dose N-acetylcysteine decreases silica-induced lung fibrosis in the rat.
    The Journal of international medical research, 2013, Volume: 41, Issue:4

    Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Hydroxyproline; Inflammation; Interleukin-8; Lung; Male; Malondialdehyde; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Tumor Necrosis Factor-alpha

2013
N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling.
    Toxicology mechanisms and methods, 2014, Volume: 24, Issue:3

    Topics: Acetylcysteine; Animals; Apoptosis; Down-Regulation; Lung; Male; Membrane Potential, Mitochondrial; Mitochondria; Procollagen; Pulmonary Fibrosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Silicon Dioxide

2014
[High-fat diet induces pulmonary fibrosis in rats and inhibitory effects of N-acetylcysteine].
    Zhonghua yi xue za zhi, 2013, Nov-26, Volume: 93, Issue:44

    Topics: Acetylcysteine; Animals; Diet, High-Fat; Disease Models, Animal; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1

2013
N-Acetylcysteine Inhibits Ventilation-Induced Collagen Accumulation in the Rat Lung.
    The Tohoku journal of experimental medicine, 2015, Volume: 236, Issue:4

    Topics: Acetylcysteine; Analysis of Variance; Animals; Collagen; Injections, Intravenous; Lung; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Tidal Volume; Time Factors

2015
[Pulmonary fibrosis].
    Medicina clinica, 2016, Feb-05, Volume: 146, Issue:3

    Topics: Acetylcysteine; Azathioprine; Clinical Trials as Topic; Forecasting; Glucocorticoids; Humans; Indoles; Multicenter Studies as Topic; Prognosis; Pulmonary Fibrosis; Pyridones

2016
[Study on the therapeutic effects of tetrandrine combined with N-acetylcysteine on experimental silicosis of rats].
    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2015, Volume: 33, Issue:7

    Topics: Acetylcysteine; Animals; Benzylisoquinolines; Disease Models, Animal; Dust; Hydroxyproline; Interleukin-6; Lung; Malondialdehyde; Pulmonary Fibrosis; Quartz; Rats; Rats, Wistar; Silicon Dioxide; Silicosis; Tumor Necrosis Factor-alpha

2015
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.
    The Lancet. Respiratory medicine, 2017, Volume: 5, Issue:1

    Topics: Acetylcysteine; Administration, Inhalation; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Vital Capacity

2017
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply.
    The Lancet. Respiratory medicine, 2017, Volume: 5, Issue:1

    Topics: Acetylcysteine; Administration, Inhalation; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Vital Capacity

2017
[Interstitial lung diseases - historical development, current status, future prospects].
    Pneumologie (Stuttgart, Germany), 2010, Volume: 64, Issue:9

    Topics: Acetylcysteine; Antioxidants; History, 19th Century; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Sarcoidosis

2010
Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I.
    American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:3

    Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Bronchoalveolar Lavage; Cells, Cultured; Dinoprost; Free Radical Scavengers; Inflammation; Lung; Macrophage Migration-Inhibitory Factors; Mice; Mice, Transgenic; Oxidative Stress; Peroxiredoxins; Pulmonary Fibrosis

2011
Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011, Volume: 18, Issue:3

    Topics: Acetylcysteine; Adenosine A2 Receptor Antagonists; Drug Interactions; Expectorants; Heart Arrest; Humans; Male; Middle Aged; Pulmonary Fibrosis; Purines; Pyrazoles; Radionuclide Imaging

2011
[Effects of high-dose N-acetylcysteine on the lung tissues of rats exposed to silica].
    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2011, Volume: 29, Issue:7

    Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Dust; Interleukin-8; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Tumor Necrosis Factor-alpha

2011
[N-acetylcysteine (NAC) inhibited pulmonary fibrosis in acute respiratory distress syndrome (ARDS)].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2011, Volume: 23, Issue:10

    Topics: Acetylcysteine; Cells, Cultured; Collagen; Fibroblasts; Glutathione; Humans; Lipopolysaccharides; Lung; Pulmonary Fibrosis; Respiratory Distress Syndrome

2011
Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation.
    The Journal of biological chemistry, 2012, Jul-20, Volume: 287, Issue:30

    Topics: Acetylcysteine; Antigens, Differentiation; Azacitidine; Bronchi; Cadherins; Cell Line, Transformed; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibronectins; Free Radical Scavengers; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Junctions; Nickel; Pulmonary Fibrosis; Reactive Oxygen Species; Respiratory Mucosa

2012
Innate immune activation by inhaled lipopolysaccharide, independent of oxidative stress, exacerbates silica-induced pulmonary fibrosis in mice.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Acetylcysteine; Administration, Inhalation; Animals; Bronchoalveolar Lavage; Cytokines; Drinking Water; Hydroxyproline; Immunity, Innate; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protein Carbonylation; Pulmonary Fibrosis; Silicon Dioxide

2012
Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats.
    Clinical toxicology (Philadelphia, Pa.), 2012, Volume: 50, Issue:8

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ascorbic Acid; Disease Models, Animal; Herbicides; Injections, Intraperitoneal; Injections, Intravenous; Life Expectancy; Male; Paraquat; Pulmonary Fibrosis; Pyridones; Rats; Rats, Wistar; Survival Rate; Vitamin E

2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
    The New England journal of medicine, 2012, 08-30, Volume: 367, Issue:9

    Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis

2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
    The New England journal of medicine, 2012, 08-30, Volume: 367, Issue:9

    Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis

2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
    The New England journal of medicine, 2012, 08-30, Volume: 367, Issue:9

    Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis

2012
[Presentation of a case of Paraquat poisoning].
    Revista espanola de anestesiologia y reanimacion, 2012, Volume: 59, Issue:3

    Topics: Acetylcysteine; Acute Kidney Injury; Adult; Ascorbic Acid; Charcoal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diuretics; Fatal Outcome; Furosemide; Gastric Lavage; Hemoperfusion; Humans; Immunosuppressive Agents; Male; Paraquat; Poisoning; Pulmonary Fibrosis; Respiration, Artificial; Respiratory Insufficiency; Rhabdomyolysis; Suicide, Attempted; Vitamin E

2012
N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
    Respiration; international review of thoracic diseases, 2012, Volume: 84, Issue:6

    Topics: Acetylcysteine; Actins; Animals; Antibiotics, Antineoplastic; Bleomycin; Collagen; Disease Models, Animal; Down-Regulation; Free Radical Scavengers; Glutathione; Idiopathic Pulmonary Fibrosis; Lung; Male; Protein-Lysine 6-Oxidase; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1

2012
Modulatory effects of curcumin and green tea extract against experimentally induced pulmonary fibrosis: a comparison with N-acetyl cysteine.
    Journal of biochemical and molecular toxicology, 2012, Volume: 26, Issue:11

    Topics: Acetylcysteine; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Camellia sinensis; Curcumin; Cyclophosphamide; Dietary Supplements; Disease Models, Animal; Inflammation Mediators; Lipid Peroxidation; Lung; Male; Plant Extracts; Plant Leaves; Protective Agents; Pulmonary Fibrosis; Rats; Rats, Wistar; Tea

2012
Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
    American journal of respiratory and critical care medicine, 2003, Mar-15, Volume: 167, Issue:6

    Topics: Acetylcysteine; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Collagen; Cysteine; Disease Models, Animal; gamma-Glutamyltransferase; Glutathione; Inflammation; Leukocyte Count; Matrix Metalloproteinase 9; Mice; Mice, Inbred Strains; Neutrophils; Pulmonary Fibrosis; Severity of Illness Index; Time Factors

2003
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
    British journal of pharmacology, 2003, Volume: 138, Issue:6

    Topics: Acetonitriles; Acetylcysteine; Animals; Antioxidants; Biomarkers; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Hydroxyproline; Immunohistochemistry; Lung; Macrophages, Alveolar; Male; NF-kappa B; Organ Size; Oxidative Stress; Pneumonia; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Trityl Compounds

2003
Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats.
    The European respiratory journal, 2003, Volume: 22, Issue:6

    Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Animals; Antibiotics, Antineoplastic; Bleomycin; Free Radical Scavengers; Gene Expression; Hyperplasia; Lung; Male; Models, Animal; Mucin 5AC; Mucins; Oxidative Stress; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley

2003
Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
    Pulmonary pharmacology & therapeutics, 2005, Volume: 18, Issue:5

    Topics: Acetylcysteine; Animals; Antioxidants; Bleomycin; Disease Models, Animal; Drug Interactions; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Thioglycolates; Thiophenes

2005
Antioxidant therapy for idiopathic pulmonary fibrosis.
    The New England journal of medicine, 2005, Nov-24, Volume: 353, Issue:21

    Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Glutathione; Humans; Lung; Prednisone; Pulmonary Fibrosis

2005
Acetylcysteine in pulmonary fibrosis.
    The New England journal of medicine, 2006, 03-09, Volume: 354, Issue:10

    Topics: Acetylcysteine; Bone Marrow; Glutathione; Humans; Methyltransferases; Pulmonary Fibrosis

2006
Acetylcysteine in pulmonary fibrosis.
    The New England journal of medicine, 2006, 03-09, Volume: 354, Issue:10

    Topics: Acetylcysteine; Humans; Outcome Assessment, Health Care; Pulmonary Fibrosis; Vital Capacity

2006
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
    The European respiratory journal, 2006, Volume: 27, Issue:4

    Topics: Acetylcysteine; Antioxidants; Azathioprine; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Prednisolone; Pulmonary Fibrosis

2006
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe?
    WMJ : official publication of the State Medical Society of Wisconsin, 2006, Volume: 105, Issue:6

    Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Evidence-Based Medicine; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity

2006
p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis.
    Experimental and molecular pathology, 2007, Volume: 83, Issue:3

    Topics: Acetylcysteine; Biomarkers; Calcium-Binding Proteins; Cell Line, Tumor; Cluster Analysis; DNA-Binding Proteins; Epithelial Cells; Gene Expression Profiling; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Keratin-14; Keratin-6; Membrane Proteins; Metaplasia; Oligonucleotide Array Sequence Analysis; Protein Isoforms; Protein Precursors; Pulmonary Fibrosis; Respiratory Mucosa; RNA, Small Interfering; Serrate-Jagged Proteins; Trans-Activators; Transcription Factors; Transforming Growth Factor beta1; Tumor Suppressor Proteins

2007
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.
    American journal of respiratory and critical care medicine, 1995, Volume: 152, Issue:3

    Topics: Acetylcysteine; Adult; Aged; Bronchoalveolar Lavage Fluid; Case-Control Studies; Epithelium; Female; Glutathione; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis

1995
Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:6

    Topics: Acetylcysteine; Allyl Compounds; Amiodarone; Animals; Antioxidants; Butylated Hydroxyanisole; Cricetinae; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Lung; Lung Diseases; Male; Mesocricetus; Oxidative Stress; Pulmonary Fibrosis; Sulfides; Superoxide Dismutase

1994
New approaches to the treatment of pulmonary fibrosis.
    The European respiratory journal, 1994, Volume: 7, Issue:3

    Topics: Acetylcysteine; Colchicine; Humans; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Terminology as Topic; Tumor Necrosis Factor-alpha

1994
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression.
    American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:6

    Topics: Acetylcysteine; Antioxidants; Bronchoalveolar Lavage Fluid; Female; Glutathione; Glutathione Disulfide; Humans; Immunosuppressive Agents; Lung; Male; Methionine; Middle Aged; Oxidative Stress; Prospective Studies; Pulmonary Fibrosis

1997
[Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression].
    Pneumologie (Stuttgart, Germany), 1998, Volume: 52, Issue:7

    Topics: Acetylcysteine; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Male; Middle Aged; Pulmonary Fibrosis

1998
Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
    American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:1

    Topics: Acetylcysteine; Administration, Inhalation; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Chemokines; Glutathione; Hydroxyproline; Lipid Peroxides; Male; Mice; Mice, Inbred ICR; Pulmonary Fibrosis

2000
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats.
    The European respiratory journal, 2001, Volume: 17, Issue:6

    Topics: Acetylcysteine; Administration, Oral; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Free Radical Scavengers; Glutathione; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Taurine

2001
Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice.
    The European respiratory journal, 1991, Volume: 4, Issue:7

    Topics: Acetylcysteine; Animals; Bleomycin; Collagen; Lung; Mice; Mice, Inbred Strains; Microscopy, Electron; Pulmonary Fibrosis

1991
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases].
    Medizinische Klinik (Munich, Germany : 1983), 1991, Jun-15, Volume: 86, Issue:6

    Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Asbestosis; Bronchoalveolar Lavage Fluid; Female; Fibroblasts; Glutathione; Humans; Male; Middle Aged; Pulmonary Fibrosis

1991
[From mucolytic agent to free radical capture: N-acetylcysteine].
    Medizinische Klinik (Munich, Germany : 1983), 1991, Jun-15, Volume: 86, Issue:6

    Topics: Acetylcysteine; Antioxidants; Expectorants; Free Radicals; Humans; Pulmonary Fibrosis

1991
Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
    The Journal of laboratory and clinical medicine, 1988, Volume: 111, Issue:6

    Topics: Acetylcysteine; Animals; Bleomycin; Collagen; Cricetinae; Lung; Male; Mesocricetus; Pulmonary Fibrosis; Sulfhydryl Compounds; Time Factors

1988